Thrombotic Microangiopathy

• CLINICAL_TRIALS trial_result · 2017-07-28
  Clinical Trial Update: Immature Platelet Fraction as a Promising Biomarker in Prediction Outcome of HELLP Syndrome

  This clinical trial update reports that immature platelet fraction may serve as a biomarker to predict outcomes in HELLP syndrome, and the s…

• CLINICAL_TRIALS other · 2015-04-15
  Clinical Trial Update: OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy

  This clinical trial update describes compassionate-use access to OMS721 (Narsoplimab) for patients with thrombotic microangiopathy under stu…

• CLINICAL_TRIALS research · 2015-02-26
  Clinical Trial Update: Screening of TMA Patients für ADAMTS13 Activity (Adamscreen)

  This document notes that the Adamscreen study (NCT02373267) is screening patients with thrombotic microangiopathy for ADAMTS13 activity, wit…

• CLINICAL_TRIALS research · 2013-06-19
  Clinical Trial Update: International Registry and Biorepository for TMA(Thrombotic Microangiopathy)

  The international registry and biorepository study for thrombotic microangiopathy, including hemolytic uremic syndrome and thrombotic thromb…

• CLINICAL_TRIALS trial_result · 2009-11-26
  Clinical Trial Update: Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy [Phase 2]

  A Phase 2 clinical trial evaluating ARC1779 for thrombotic microangiopathy was terminated.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.